1. Home
  2. HURN vs IRON Comparison

HURN vs IRON Comparison

Compare HURN & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huron Consulting Group Inc.

HURN

Huron Consulting Group Inc.

HOLD

Current Price

$132.43

Market Cap

2.1B

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$67.14

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HURN
IRON
Founded
2002
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.3B
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
HURN
IRON
Price
$132.43
$67.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
11
Target Price
$204.40
$103.18
AVG Volume (30 Days)
172.6K
265.6K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
5.84
N/A
Revenue
$1,699,143,000.00
N/A
Revenue This Year
$11.80
N/A
Revenue Next Year
$8.23
$283.52
P/E Ratio
$22.62
N/A
Revenue Growth
11.65
N/A
52 Week Low
$116.12
$40.00
52 Week High
$186.78
$99.50

Technical Indicators

Market Signals
Indicator
HURN
IRON
Relative Strength Index (RSI) 55.47 50.89
Support Level $131.85 $57.79
Resistance Level $136.05 $69.36
Average True Range (ATR) 4.74 2.62
MACD 0.92 -0.37
Stochastic Oscillator 86.83 32.16

Price Performance

Historical Comparison
HURN
IRON

About HURN Huron Consulting Group Inc.

Huron Consulting Group Inc is a professional services firm. The company provides expertise in technology, operations, advisory services, & analytics through three operating segments namely Healthcare, Education, and Commercial. Healthcare segment helps the firms to transform and innovate the delivery model to focus on patient wellness by improving quality outcomes, minimizing care variation and fundamentally improving patient and population health, Education segment provides management consulting and technology solutions, and Commercial segment is focused on serving industries and organizations facing disruption and regulatory change. It generates a majority of its revenue from the Healthcare Segment.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: